Understanding pancreas size may help unlock cause of Type 1 diabetes

December 12, 2012, University of Florida

(Medical Xpress)—People at risk for Type 1 diabetes may have fewer insulin-producing "beta" cells than people not at risk, a finding that could help researchers shed light on what causes the disease, a new University of Florida study shows.

The study, which will be published Wednesday (Dec. 12) in the , revealed that people at risk for Type 1 diabetes had smaller pancreases than people who were not at risk.

"This is the first time this has been noted," said Martha Campbell-Thompson, a professor in the UF College of Medicine department of pathology, immunology and laboratory medicine. "We still don't know what causes Type 1 diabetes, but if people have fewer to begin with, other confounding factors such as a virus or genetics could help push them over into having . There are a lot of possibilities."

Type 1 diabetes occurs when the body's immune system begins attacking its own beta cells in the , which are responsible for producing insulin the body needs to convert sugar into energy. The beta cells stop producing insulin, often beginning in childhood. Because of this, patients must take insulin for the rest of their lives. This differs from the more common , which often can be prevented and treated through lifestyle changes, such as improved diet and increased exercise.

Although genetics plays a big role, researchers still don't know what triggers this , and after it begins, there is no going back, said Campbell-Thompson, director of the pathology core for the Network for Pancreatic with Diabetes, or nPOD, a human pancreas biorepository housed within the UF Diabetes Center of Excellence.

In the current study, Campbell-Thompson and colleagues at the City of Hope National Medical Center examined 164 pancreases from adult organ donors, including those with auto-antibodies linked to an increased risk for Type 1 diabetes. After examining the organs and comparing them with control samples, the researchers discovered that the people at risk for Type 1 diabetes had pancreases roughly three-fourths the size of those of patients not at risk for the disease. In addition, patients already diagnosed with Type 1 diabetes had pancreases about half the size of control samples, Campbell-Thompson said.

"Had they not become organ donors, these people might have eventually developed Type 1 diabetes, so we were trying to carefully characterize their pancreases and their insulin-producing cells to see what was going on. A simple part of that was just weighing the pancreas when we got it," she said. "As we got more and more of these donors, a trend started showing up that these pancreases weighed less. They weighed lower than normal controls."

The ultimate goal of the research, and nPOD, which provides pancreas samples to researchers across the country, is to first understand how the pancreas works and then uncover new and better ways to not only treat Type 1 diabetes, but also to prevent it.

"Thanks to nPOD's valuable and rapidly growing collection of pancreas samples and other tissues, its team of researchers was able to examine, for the first time, the pancreas weight of those at risk for developing Type 1 diabetes," said Teodora Staeva, program director for immune therapies at JDRF, the leading foundation focused on advancing Type 1 diabetes research, which funded the study. "The findings raise significant questions about the development and progression of Type 1 diabetes."

Obtaining and analyzing human pancreas samples has proved crucial for researchers because mouse models used to uncover new treatments for Type 1 diabetes are no longer considered good examples of the disease in humans.

"There are major differences between human Type 1 and the animal models," Campbell-Thompson said. "It's really changing some of our ideas about when this autoimmune attack might occur, and we still don't know all the players."

The researchers now hope to take the study a step further by using noninvasive methods such as magnetic resonance imaging, or MRI, to gauge pancreas size in live patients.

"This could really change some of the ideas we have about ," Campbell-Thompson said. "By understanding how it develops we can think of new ways to treat it."

Explore further: Insulin signaling is distorted in pancreases of Type 2 diabetics

Related Stories

Insulin signaling is distorted in pancreases of Type 2 diabetics

December 13, 2011
Insulin signaling is altered in the pancreas, a new study shows for the first time in humans. The errant signals disrupt both the number and quality of beta cells — the cells that produce insulin.

Pancreas stem cell discovery may lead to new diabetes treatments

November 14, 2012
(Medical Xpress)—Stem cells in the adult pancreas have been identified that can be turned into insulin producing cells, a finding that means people with type 1 diabetes might one day be able to regenerate their own insulin-producing ...

Connexins: Providing protection to cells destroyed in Type 1 diabetes

November 7, 2011
Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone ...

Researchers identify pivotal immune cell in Type 1 diabetes in humans

January 12, 2012
(Medical Xpress) -- Researchers at the La Jolla Institute for Allergy & Immunology have proven – for the first time in human tissues -- the specific immune system T cells which trigger the destruction of type 1 diabetes ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Thirty-year study shows women who breastfeed for six months or more reduce their diabetes risk

January 16, 2018
In a long-term national study, breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years, according to new Kaiser Permanente research published ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

DavidW
not rated yet Dec 12, 2012
We now know the cause and cure for Type II:
https://www.youtu...embedded

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.